Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
TOC66
TOC49
Masthead39
PARP inhibitors for prostate cancer26
Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study21
Breast cancer care: Looking for the new normal20
Current and prospective antibody-based therapies in multiple myeloma19
A narrative review of the principal glucocorticoids employed in cancer19
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks17
Seminars in oncology 50th anniversary15
Masthead13
Lung Cancer Screening and Precision Oncology13
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients12
TOC12
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?12
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review12
0.031354904174805